throbber
Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 1 of 17 PageID #: 1
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF NEW YORK
`
`---------------------------------------------------------------- x
`
`SILVER DEALS LLC,
`
`Plaintiff,
`
`v.
`
`ULAI HEALTH LLC, CHANHEE PAUL KANG,
`and PHARBEST PHARMACEUTICALS, INC.,
`
`Defendants.
`---------------------------------------------------------------- x
`
`Civil Action No. 22-cv-4384
`
`COMPLAINT AND JURY TRIAL
`DEMAND
`
`Electronically Filed
`
`:::::::::::::
`
`Plaintiff Silver Deals, LLC (“Plaintiff”), by and through its counsel, hereby brings this
`
`Complaint against Ulai Health LLC (“Ulai”), Chanhee Paul Kang (together with Defendant Ulai,
`
`“Ulai Defendants”), and Pharbest Pharmaceuticals, Inc. (“Pharbest”) (individually and
`
`collectively, “Defendants”) and alleges as follows:
`
`PARTIES
`
`1.
`
`Plaintiff is a limited liability company existing under the laws of the State of New
`
`York, with an address at 22 Lizensk Boulevard, Unit 101, Monroe, New York 10950.
`
`2.
`
`On information and belief, Defendant Ulai Health LLC is limited liability
`
`company existing under the laws of the State of Virginia, with an address at 5799 Burke Centre
`
`Parkway, Suite L, Burke, Virgina 22015.
`
`3.
`
`On information and belief, Defendant Chanhee Paul Kang is a member or
`
`manager of Defendant Ulai Health LLC and has a registered office address of 5799 Burke Centre
`
`Parkway, Suite L, Burke, Virgina 22015.
`
`-1-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 2 of 17 PageID #: 2
`
`4.
`
`On information and belief, Defendant Pharbest Pharmaceuticals, Inc. is a
`
`corporation existing under the laws of the State of New York, with an address at 14 Engineers
`
`Lane, Farmingdale, New York 11735.
`
`JURISDICTION AND VENUE
`
`5.
`
`The Court has subject matter jurisdiction over this action pursuant to the Federal
`
`Declaratory Judgment Act, 28 U.S.C. §§ 2201 and 2202; the Trademark Act of 1946, as
`
`amended, 15 U.S.C. § 1051 et seq., including 15 U.S.C. § 1121; and 28 U.S.C. §§ 1331, 1338,
`
`and 1367.
`
`6.
`
`Furthermore, Defendants are subject to general and specific jurisdiction in this
`
`Court, inter alia, because they conduct business in this District and have committed at least some
`
`of the acts complained of herein within this District.
`
`7.
`
`On information and belief, Defendant Pharbest is a manufacturer, and the Ulai
`
`Defendants are wholesale distributors, of pharmaceutical products and regularly solicit business
`
`from, do business with, and/or derive revenue from consumers in New York; Defendants have
`
`substantial and continuous contacts with New York; and Defendants otherwise avail themselves
`
`of the privilege of doing business in the State of New York and in this District.
`
`8.
`
`Defendants have purposely directed their activities, including the illegal acts
`
`against Plaintiff described below, toward this District and this action arises from those activities.
`
`9.
`
`Specifically, at all relevant times, Defendants were aware that Plaintiff resided in
`
`New York and that their illegal acts would cause harm to Plaintiff in New York. Specifically,
`
`Plaintiff’s Amazon storefront identifies Plaintiff’s place of business in New York.
`
`10.
`
`Venue in this District is proper under 28 U.S.C. §1391(b) because a substantial
`
`part of the events giving rise to the claims occurred in this District and Defendants are subject to
`
`personal jurisdiction in this District.
`
`-2-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 3 of 17 PageID #: 3
`
`BACKGROUND FACTS
`
`11.
`
`On information and belief, Defendant Pharbest is the manufacturer of
`
`pharmaceuticals (“Pharbest Products”).
`
`12.
`
`On information and belief, Defendant Pharbest is the owner of U.S. Trademark
`
`Registration No. 6306639 for PHARBEST word and design mark (“the Pharbest Registration”).
`
`13.
`
`On information and belief, Defendant Ulai is a wholesale distributor of, inter alia,
`
`pharmaceuticals and nutritional supplements, including Pharbest Products.
`
`14.
`
`On information and belief, Defendant Ulai is the owner of U.S. Trademark
`
`Registration No. 5930566 for ULAI (“the Ulai Registration”).
`
`15.
`
`On information and belief, Defendant Pharbest is a contracted manufacturer of
`
`Pharbest Products for Defendants.
`
`16.
`
`Plaintiff is in the business of lawfully acquiring and re-selling various health and
`
`beauty products for a profit, including Pharbest Products.
`
`17.
`
`Plaintiff purchases Pharbest Products directly from the manufacturer, Defendant
`
`Pharbest.
`
`18.
`
`The Pharbest Products acquired and re-sold by Plaintiff are not materially
`
`different from the Pharbest Products sold by Defendants.
`
`19.
`
`Plaintiff resells products, including Pharbest Products, through an Amazon
`
`storefront, “VerSure.”
`
`20.
`
`Since its formation, Plaintiff has served hundreds of thousands of customers
`
`through its Amazon storefront.
`
`21.
`
`Defendants’ illegal actions have irreparably damaged, and threaten to destroy,
`
`Plaintiff’s successful business.
`
`-3-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 4 of 17 PageID #: 4
`
`ONLINE MARKETPLACES
`
`22.
`
`23.
`
`Upon information and belief, Amazon is the world’s largest online retailer.
`
`According to published reports, “Amazon’s market cap alone is bigger than the
`
`nine biggest U.S. retailers put together.” Dorothy Neufeld, Visualizing the Size of Amazon, the
`
`World’s Most Valuable Retailer, Visual Capitalist (July 2, 2020),
`
`https://www.visualcapitalist.com/amazon-worlds-most-valuable-retailer/.
`
`24.
`
`Amazon’s online e-commerce platform allows for third parties, like Plaintiff, to
`
`sell products on its e-commerce platform.
`
`25.
`
`The privilege of selling on Amazon is highly advantageous, as Amazon provides
`
`third parties with exposure to the world marketplace on a scale that no other online retailer can
`
`currently provide.
`
`26.
`
`Plaintiff has had a contractual and business relationship with Amazon, such that
`
`Plaintiff was and is permitted to sell products on Amazon's e-commerce platform.
`
`27.
`
`Third-party sellers, like Plaintiff, create an online storefront on Amazon. When a
`
`customer buys a product on Amazon, the customer can see the online store from which the
`
`customer is purchasing a product. Thus, Plaintiff has the online equivalent of a brick-and-mortar
`
`store.
`
`28.
`
`A significant portion of Plaintiff’s business is derived from the sale of products on
`
`Amazon and, in particular, through its Amazon storefront.
`
`29.
`
`Once Plaintiff acquires products from reputable sources, Plaintiff resells the same
`
`products on Amazon at a profit.
`
`30.
`
`In general, transactions on Plaintiff’s Amazon storefront are completed by
`
`Amazon, whereby Amazon ships Plaintiff’s products from an Amazon warehouse (known as
`
`“Fulfilment by Amazon” or “FBA”).
`
`-4-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 5 of 17 PageID #: 5
`
`31.
`
`Plaintiff has invested significant efforts into building a successful and reputable
`
`Amazon storefront.
`
`32.
`
`Plaintiff’s Amazon storefront has amassed over one-hundred thousand reviews
`
`and holds a 100% positive lifetime rating.
`
`33.
`
`A small sample of Plaintiff’s recent reviews are shown below:
`
`34.
`
`Any harm that comes to the relationship between Plaintiff and Amazon creates a
`
`potential for serious and irreparable injury to Plaintiff.
`
`DEFENDANTS’ ATTEMPT TO STIFLE COMPETITION BY FILING FALSE
`INTELLECTUAL PROPERTY COMPLAINTS
`
`35.
`
`On information and belief, the Ulai Defendants seek to increase its profits by
`
`controlling the distribution and pricing of products, including Pharbest Products, through
`
`unlawful means.
`
`36.
`
`As demonstrated below, the Ulai Defendants have engaged in a coordinated effort
`
`to preclude select third parties, including Plaintiff, from reselling genuine Pharbest Products on
`
`online marketplaces by making false allegations of intellectual property infringement and by
`
`making defamatory statements.
`
`-5-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 6 of 17 PageID #: 6
`
`37.
`
`On information and belief, the purpose of these false complaints and defamatory
`
`statements was to damage Plaintiff’s reputation and goodwill, such that Amazon would suspend
`
`or terminate its relationship with Plaintiff, thereby preventing Plaintiff from selling genuine
`
`Pharbest Products on Amazon.
`
`38.
`
`Because Plaintiff sells only genuine Pharbest Products through its Amazon
`
`storefront that are not materially different from the Pharbest Products sold by Defendants, none
`
`of the Defendants have any legitimate intellectual property claim(s) against Plaintiff.
`
`39.
`
`Under the first sale doctrine, Plaintiff is lawfully permitted to resell Pharbest
`
`Products without violating the intellectual property rights or other legal rights of Defendants.
`
`40.
`
`The first sale doctrine provides that, once a manufacturer places a product in the
`
`stream of commerce through its first sale, it can no longer enforce its intellectual property rights
`
`with regard to resellers, so long as the resellers are selling authentic, unaltered products.
`
`41.
`
`It is well-known among brand owners that Amazon has a policy of acting on
`
`virtually any notice of intellectual property infringement, whether legitimate or not.
`
`42.
`
`As one Amazon expert explained:
`
`In order to meet a minimum liability standard, Amazon will act upon properly
`submitted and completed notice claims of infringement. They will notify specified
`marketplace sellers which party reported them, on what listing, and how to reach
`that would-be rights owner via email. The rest though, is up to you. And, unless
`you (and possibly your legal team) can prove that the Notice claim is false, Amazon
`considers it valid and actionable.
`
`Unfortunately, word is out among potential Notice claim abusers that anyone can
`submit a form. Amazon [is] not worried about additional vetting or verification
`processes. Investigators merely check the form for completed content in all the right
`spaces, kill the listings and send off the notifications.
`
`They don’t independently verify that any of the information is actually correct, or
`valid. The rights owner makes a legally-binding declaration in the form, and signs
`it.
`
`-6-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 7 of 17 PageID #: 7
`
`See Chris McCabe, False Infringement Claims are Rife on Amazon, WebRetailer (Apr. 11,
`
`2018), https://www.webretailer.com/lean-commerce/false-infringement-claims-amazon/
`
`(emphasis added).
`
`43.
`
`On information and belief, the Ulai Defendants were, at all relevant times, aware
`
`of the foregoing Amazon policy with respect to reports of intellectual property infringement.
`
`44.
`
`On information and belief, the Ulai Defendants were, at all relevant times, aware
`
`that Amazon acts on reports of counterfeit products, regardless of the truth of the report.
`
`45.
`
`The Ulai Defendants filed multiple false complaints with Amazon that alleged
`
`that Plaintiff was selling counterfeit Pharbest Products.
`
`46.
`
`The Ulai Defendants knew, or should have known, that such allegations were
`
`false.
`
`47.
`
`Each complaint submitted to Amazon was signed under penalty of perjury by an
`
`employee or agent of the Ulai Defendants.
`
`48.
`
`For example, when submitting an infringement report to Amazon, an intellectual
`
`property rights owner must read and accept the following statements:
`
`“I have a good faith belief that the content(s) described above violate(s) my rights
`described above or those held by the rights owner, and that the use of such
`content(s) is contrary to law.”
`
`“I declare, under penalty of perjury, that the information contained in this
`notification is correct and accurate and that I am the owner or agent of the owner
`of the rights described above.”
`
`Report Infringement, Amazon, https://www.amazon.com/report/infringement (last visited
`
`October 31, 2019).
`
`49.
`
`Once confirmed through discovery, all other individual(s) responsible for the false
`
`complaints described below, will be added as defendants in this action.
`
`-7-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 8 of 17 PageID #: 8
`
`50.
`
`For example, on or about March 10, 2022, Plaintiff received a notice from
`
`Amazon stating as follows:
`
`Hello,
`
`We received a report from a rights owner that you are listing counterfeit products.
`Sellers on Amazon..com are not allowed to create listings or detail pages for
`counterfeit goods.
`
`We removed the content listed at the end of this email. We may let you list this
`product again if we receive a retraction from the rights owner. Their contact
`information can be found below.
`
`Anna Park
`your.resume6555@gmail.com
`
`How do I reactivate my listing?
`Please visit the Account Health page in Seller Central
`(https://sellercentral.amazon.com/performance/dashboard?ref=ah_em_nr) to
`appeal this listing deactivation. Please click on the “Appeal” link next to the
`listing in the “Product and Policy Violations" section on the account health page.
`
`If the rights owner does not retract their complaint, or you do not provide
`supporting information, we may provide your contact information to the rights
`owner upon their request.
`
`We consider allegations of counterfeit a serious matter and your account is under
`review. If we receive more complaints about your listings, we may not allow you
`to sell on Amazon.com.
`
`To learn more about this policy, search for “Intellectual Property Violations” in
`Seller Central Help.
`ASIN: B0879CVM2Z
`Title: Senna Tablets 100 Ct. ! Natural Vegetable Laxative [Made in USA] !
`Laxatives for Constipation, Colon Cleanser, Detox Cleanse, Constipation Relief
`for Adults Kids 8.6mg, Stool Softener Plus (1 Bottle)
`Infringement type: Counterfeit
`Trademark: 5930566
`Complaint ID: 9755081191
`
`51.
`
`The above report relates to a Pharbest Product, which is referenced by its Amazon
`
`Standard Identification Numbers (“ASIN”).
`
`-8-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 9 of 17 PageID #: 9
`
`52.
`
`53.
`
`The Pharbest Product identified in the above report was genuine.
`
`On information and belief, prior to filing the above complaint, the Ulai
`
`Defendants knew, or should have known, that the Pharbest Product sold by Plaintiff was not
`
`counterfeit and did not infringe the Ulai Registration and/or the Pharbest Registration.
`
`54.
`
`On information and belief, the Ulai Defendants’ allegation that the above Pharbest
`
`Product was counterfeit was knowingly false and made in bad faith.
`
`DEFENDANTS REFUSE TO CEASE SUBMITTING
`FALSE COMPLAINTS TO AMAZON
`
`55.
`
`The above false report is part of an ongoing and continuous course of conduct by
`
`the Ulai Defendants to interfere with Plaintiff’s ability to resell Pharbest Products.
`
`56.
`
`On or about March 10, 2022, the Ulai Defendants filed a series of false
`
`complaints with Amazon alleging sales of counterfeit Pharbest Products, resulting in suspension
`
`of at least six of Plaintiff’s listings.
`
`57.
`
`On or about June 29, 2022, Plaintiff wrote to all Defendants requesting that
`
`Defendants retract the false complaints, as the Pharbest Products it sold were not counterfeit.
`
`58.
`
`The Ulai Defendants responded that they would retract the complaints “out of
`
`good will” if Plaintiff agreed to no longer sell any products on Ulai’s Amazon listings.
`
`59.
`
`Plaintiff confirmed in writing that it would refrain from sales on Ulai’s product
`
`listings on Amazon.
`
`60.
`
`On or about July 19, 2022, when the complaints had still not been retracted,
`
`Plaintiff’s counsel wrote to the Ulai Defendants again requesting that the Ulai Defendants
`
`immediately retract the false complaints.
`
`61.
`
`To date, the Ulai Defendants have failed to retract the false complaints.
`
`-9-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 10 of 17 PageID #: 10
`
`HARM TO PLAINTIFF
`
`62.
`
`As a result of each of the above false intellectual property complaints submitted to
`
`Amazon, Plaintiff’s listings relating to the Pharbest Products were suspended, resulting in an
`
`immediate loss of revenue.
`
`63.
`
`It is well-known that complaints to Amazon put Amazon sellers in jeopardy of a
`
`full selling suspension, meaning that Plaintiff’s ability to sell any and all products on Amazon
`
`would be lost.
`
`64.
`
`On information and belief, the Ulai Defendants were aware that complaints to
`
`Amazon, particularly those alleging trademark infringement, result in selling suspensions.
`
`65.
`
`On information and belief, the Ulai Defendants have used these same tactics,
`
`namely filing false intellectual property complaints, against other Amazon sellers.
`
`66.
`
`At no time has Plaintiff ever sold Pharbest Products that infringed any of
`
`Defendants’ intellectual property or other legal rights.
`
`67.
`
`The Pharbest Products sold by Plaintiff were, at all times, authentic products
`
`bearing the name of the manufacturer, and were otherwise, at all times, sold lawfully.
`
`68.
`
`69.
`
`The Ulai Defendants knowingly made false complaints against Plaintiff.
`
`Upon information and belief, the true purpose of these complaints was to ensure
`
`the suspension of Plaintiff’s marketplace listings, control pricing and eliminate fair competition.
`
`70.
`
`As a result of the Ulai Defendants’ false complaints, Plaintiff’s performance
`
`metrics were irreparably damaged.
`
`71.
`
`It is well-known that as much as 90% of all Amazon sales occur from Amazon’s
`
`“buy box,” a section of an Amazon product detail page where customers can add a product to
`
`their cart.
`
`-10-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 11 of 17 PageID #: 11
`
`72.
`
`Amazon determines which seller gets the “buy box” based on a number of factors,
`
`including the seller’s performance metrics.
`
`73.
`
`The Ulai Defendants’ false complaints have damaged Plaintiff’s metrics and
`
`caused Plaintiff to lose the “buy box” on many of its product listings.
`
`COUNT I - DECLARATORY JUDGMENT OF NON-INFRINGEMENT
`
`(No Trademark Infringement)
`
`Plaintiff realleges and incorporates all previous paragraphs.
`
`Defendant Pharbest manufactures Pharbest Products and places such products into
`
`74.
`
`75.
`
`the stream of commerce.
`
`76.
`
`Plaintiff stocks, displays, and resells new, genuine Pharbest Products, each
`
`bearing the true PHARBEST mark, the subject of the Pharbest Registration.
`
`77.
`
`The Pharbest Products sold by Plaintiff were genuine and in their original
`
`packaging.
`
`78.
`
`Plaintiff has not infringed any valid and enforceable intellectual property right
`
`owned by Defendants, including the Ulai Registration and/or Pharbest Registration.
`
`79.
`
`The Ulai Defendants’ complaints have caused the suspension of Plaintiff’s selling
`
`privileges as they relate to Pharbest Products.
`
`80.
`
`The Ulai Defendants’ complaints have put Plaintiff in jeopardy of permanent
`
`suspension of all selling privileges, which will cause extraordinary, irreparable, and untold
`
`damage on a business that is in the virtually exclusive business of selling products on e-
`
`commerce platforms.
`
`81.
`
`Under these facts, an actual, present, and justiciable controversy has arisen
`
`between Plaintiff and Defendants concerning the issue of Plaintiff’s right to sell Pharbest
`
`-11-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 12 of 17 PageID #: 12
`
`Products bearing the true PHARBEST mark, and more specifically, whether the Pharbest
`
`Products sold by Plaintiff are counterfeit and infringe any of Defendants’ trademarks.
`
`82.
`
`Plaintiff is entitled to a declaratory judgment that it has not violated Defendants’
`
`trademark rights or other rights, whether under Federal or State law.
`
`COUNT II – DEFAMATION
`
`Plaintiff realleges and incorporates all previous paragraphs.
`
`The Ulai Defendants published false statements to Amazon regarding Plaintiff as
`
`83.
`
`84.
`
`described in this Complaint, including reporting to Amazon that Plaintiff sold counterfeit
`
`Pharbest Products.
`
`85.
`
`Plaintiff did not sell counterfeit Pharbest Products or infringe the Ulai
`
`Registration or Pharbest Registration.
`
`86.
`
`The Ulai Defendants’ false statements were injurious to Plaintiff’s business
`
`because they caused Amazon to suspend Plaintiff’s selling privileges related to the Pharbest
`
`Products.
`
`87.
`
`The Ulai Defendants’ false statements were injurious to Plaintiff’s business
`
`because they caused Amazon and Plaintiff’s customers to avoid purchasing products from
`
`Plaintiff.
`
`88.
`
`Upon information and belief, the Ulai Defendants were, at a minimum, negligent
`
`in making the false statements to Amazon because, among other things, the Ulai Defendants
`
`knew that Plaintiff sells genuine products.
`
`89.
`
`90.
`
`The Ulai Defendants’ false statements are not protected by any privilege.
`
`The Ulai Defendants acted with actual malice or with reckless disregard for the
`
`truth of the matter contained in the Ulai Defendants’ false statements to Amazon and Plaintiff’s
`
`customers.
`
`-12-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 13 of 17 PageID #: 13
`
`91.
`
`False statements that are directed to the honesty, efficiency, or other business
`
`character traits amount to defamation per se.
`
`92.
`
`Here, the Ulai Defendants published statements that Plaintiff sold counterfeit
`
`Pharbest Products.
`
`93.
`
`94.
`
`The Ulai Defendants’ false statements constitute defamation per se.
`
`Additionally, Plaintiff incurred special harm, including, but not limited to,
`
`suspension from selling Pharbest Products and damage to its relationship with Amazon and its
`
`customers.
`
`95. Whether by defamation per se or by special harm, Plaintiff has suffered injury as
`
`Plaintiff’s selling privileges related to Pharbest Products have been suspended and Plaintiff has
`
`lost sales of Pharbest Products and many other products.
`
`96.
`
`97.
`
`Plaintiff is entitled to damages, costs, and fees as allowed by law.
`
`Plaintiff has suffered injury and, unless the Ulai Defendants are enjoined from
`
`such activity, will continue to suffer injury.
`
`COUNT III – TRADE LIBEL
`
`Plaintiff realleges and incorporates all previous paragraphs.
`
`The Ulai Defendants knowingly published false and derogatory statements
`
`98.
`
`99.
`
`regarding Plaintiff’s business.
`
`100.
`
`Specifically, the Ulai Defendants published false and materially derogatory
`
`statements that Plaintiff was selling counterfeit Pharbest Products.
`
`101.
`
`The Ulai Defendants’ statements that Plaintiff was selling counterfeit Pharbest
`
`Products were calculated to prevent others (including Amazon and Amazon’s customers) from
`
`doing business with Plaintiff and interfered with Plaintiff’s business relationships with these
`
`parties.
`
`-13-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 14 of 17 PageID #: 14
`
`102. As discussed above, on information and belief, the Ulai Defendants knew that
`
`submitting false complaints to Amazon would cause Amazon to suspend Plaintiff’s product
`
`listings.
`
`103.
`
`Plaintiff suffered special damages as a result of the Ulai Defendants’ statements in
`
`the form of lost dealings.
`
`104. As a result of the Ulai Defendants’ false complaints, Plaintiff’s product listings
`
`were removed from Amazon resulting in a direct and immediate loss in revenue.
`
`105.
`
`106.
`
`Plaintiff is entitled to damages, costs, and fees as allowed by law.
`
`Plaintiff has suffered injury and, unless the Ulai Defendants are enjoined from
`
`such activity, will continue to suffer injury.
`
`COUNT IV – TORTIOUS INTERFERENCE WITH
`CONTRACT AND BUSINESS RELATIONS
`
`Plaintiff realleges and incorporates all previous paragraphs.
`
`Plaintiff has had an advantageous business relationship with Amazon, which
`
`107.
`
`108.
`
`allows Plaintiff to sell on Amazon’s e-commerce platform as a third-party seller.
`
`109.
`
`Plaintiff is also in a contractual relationship with Amazon. Specifically, Plaintiff
`
`has entered into the Amazon Services Business Solutions Agreement (“BSA”) with Amazon.
`
`110.
`
`The BSA, including Paragraph S-1.2: (1) allows Plaintiff to list products for sale
`
`on the Amazon marketplace and promote the products; and (2) requires that Amazon process
`
`orders and remit payment to Plaintiff for sales.
`
`111. At all relevant times, the Ulai Defendants were aware of Plaintiff’s business
`
`relationship with Amazon, as well as Plaintiff’s contractual relationship with Amazon.
`
`-14-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 15 of 17 PageID #: 15
`
`112. At all relevant times, the Ulai Defendants were aware of the terms and conditions
`
`of Amazon’s BSA and related policies, as well as the advantageous business relationship that
`
`comes with being an Amazon seller.
`
`113.
`
`The Ulai Defendants intentionally and improperly interfered with Plaintiff’s
`
`advantageous and contractual relationship with Amazon by complaining, in writing, to Amazon,
`
`that Plaintiff was selling counterfeit products.
`
`114.
`
`The Ulai Defendants’ conduct directly and proximately caused disruption of
`
`Plaintiff’s relationship and contract with Amazon, including a breach of Paragraph S-1.2 of the
`
`BSA.
`
`115.
`
`The Ulai Defendants intended to cause Amazon to suspend Plaintiff’s ability to
`
`sell Pharbest Products on Amazon and therefore interfere with the business relationship Amazon
`
`had with Plaintiff.
`
`116.
`
`The Ulai Defendants had actual knowledge that its actions would cause Amazon
`
`to suspend Plaintiff’s ability to sell Pharbest Products on Amazon.
`
`117.
`
`The Ulai Defendant’s accusations of counterfeiting, made directly to Amazon,
`
`were for the improper purpose of suppressing competition.
`
`118.
`
`The Ulai Defendants’ actions interfered with Plaintiff’s business relationship with
`
`Amazon and proximately caused Plaintiff’s listing of Pharbest Products to be suspended.
`
`119.
`
`The Ulai Defendants’ accusations were false and were made maliciously and with
`
`ill will.
`
`120.
`
`Plaintiff has been damaged by suspension of these listings by losing revenue
`
`related to Pharbest Products.
`
`121.
`
`Plaintiff is entitled to damages, costs and attorneys’ fees as allowed by law.
`
`-15-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 16 of 17 PageID #: 16
`
`122.
`
`Plaintiff has suffered injury and, unless the Ulai Defendants are enjoined from
`
`such activity, will continue to suffer injury.
`
`WHEREFORE, the Plaintiff prays for judgment as follows:
`
`PRAYER FOR RELIEF
`
`A.
`
`An order declaring that Plaintiff has not infringed any valid and enforceable
`
`intellectual property right owned by Defendants, including the Ulai Registration and Pharbest
`
`Registration;
`
`B.
`
`Preliminary and permanent injunctive relief restraining Defendants, their agents,
`
`servants, employees, successors and assigns, and all others in concert and privity with
`
`Defendants, from filing complaints with Amazon and any other e-commerce platform;
`
`C.
`
`Injunctive relief requiring the Ulai Defendants to rescind all complaints that they
`
`have filed against Plaintiff;
`
`D.
`
`An award of all damages that Plaintiff has suffered as a result of the Ulai
`
`Defendants’ defamation;
`
`E.
`
`An award of all damages that Plaintiff has suffered as a result of the Ulai
`
`Defendants’ trade libel;
`
`F.
`
`An award of all damages that Plaintiff has suffered as a result of the Ulai
`
`Defendants’ tortious interference;
`
`G.
`
`H.
`
`An award of all costs and fees incurred in this Action; and
`
`Such other and further relief as the Court shall find just and proper.
`
`DEMAND FOR JURY TRIAL
`
`Plaintiff hereby requests a jury trial for all issues triable by jury including, but not limited
`
`to, those issues and claims set forth in any amended complaint or consolidated action.
`
`-16-
`
`

`

`Case 2:22-cv-04384 Document 1 Filed 07/26/22 Page 17 of 17 PageID #: 17
`
`Dated: July 26, 2022
`
`Respectfully submitted,
`
`TARTER KRINSKY & DROGIN LLP
`
`By: s/ Tuvia Rotberg
`Tuvia Rotberg
`1350 Broadway
`New York, NY 10018
`Tel.:
`(212) 216-8000
`Fax:
`(212) 216-8001
`E-mail: trotberg@tarterkrinsky.com
`
`Attorneys for Plaintiff
`
`-17-
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket